Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Announcements
Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Fact Accredited
GW Cancer Center Stem Cell Transplant and Cellular Therapy Program Receives FACT Accreditation for Adult Autologous Hematopoietic Progenitor Cellular Therapy
The George Washington University (GW) Cancer Center has achieved internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT).
Melissa Bucklin, PA-C
Melissa Bucklin, PA-C, Joins GW Cancer Center as a Gynecologic Oncology Physician Assistant
The George Washington (GW) Cancer Center is pleased to announce the addition of Melissa Bucklin, PA-C, to its team as a Gynecologic Oncology Physician Assistant (PA).
Evens Douglas
Five Questions with Doug Evans, PhD, MA
Doug Evans looks at the world through different lenses. As the Director of the BRIGHT Institute at the Milken Institute School of Public Health, he leads research on the influence of digital technology on public health behaviors. As a collector of old and inaccurate maps, he sees the world through…